You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 302 No. 2, July 8, 2009 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •HIV/AIDS
 •Medical Practice
 •Medical Practice, Other
 •Public Health, Other
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment for Individuals With HIV/AIDS Following Release From Prison

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Dr Baillargeon and colleagues1 offered compelling evidence of the poor continuity of care for individuals with human immunodeficiency virus (HIV)/AIDS transitioning to community-based health care following release from prison. This study documented discontinuity in antiretroviral therapy, but many other chronic medical conditions are affected by poor transitions of care, including diabetes, asthma, and mental illness. Disenrollment of inmates from Medicaid, Medicare, and veterans' benefits during incarceration means that even those eligible for such benefits face substantial lag time in re-enrollment at release. Former inmates may resort to costly health care utilization to have basic medical needs met,2 resulting in inappropriate use of scarce public resources for health care. Discharge planning through the AIDS Drug Assistance Program may help reduce discontinuities in prescription drug treatment for individuals with HIV/AIDS, but for most inmates with chronic disease, such programs are unavailable. Interruptions in care can result in increased recidivism, . . . [Full Text of this Article]

Ingrid A. Binswanger, MD, MPH
ingrid.binswanger@ucdenver.edu
University of Colorado Denver School of Medicine

Hal S. Wortzel, MD
Denver VA
Denver, Colorado



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Accessing Antiretroviral Therapy Following Release From Prison
Jacques Baillargeon, Thomas P. Giordano, Josiah D. Rich, Z. Helen Wu, Katherine Wells, Brad H. Pollock, and David P. Paar
JAMA. 2009;301(8):848-857.
ABSTRACT | FULL TEXT  

RELATED LETTERS

Treatment for Individuals With HIV/AIDS Following Release From Prison
Keith Barton
JAMA. 2009;302(2):147-148.
EXTRACT | FULL TEXT  

Treatment for Individuals With HIV/AIDS Following Release From Prison—Reply
Jacques Baillargeon, David P. Paar, and Josiah D. Rich
JAMA. 2009;302(2):148.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.